150 related articles for article (PubMed ID: 38132178)
1. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models.
Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
[TBL] [Abstract][Full Text] [Related]
2. Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.
Yuan P; Ito K; Perez-Lorenzo R; Del Guzzo C; Lee JH; Shen CH; Bosenberg MW; McMahon M; Cantley LC; Zheng B
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18226-31. PubMed ID: 24145418
[TBL] [Abstract][Full Text] [Related]
3. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
4. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.
Rajeshkumar NV; Yabuuchi S; Pai SG; De Oliveira E; Kamphorst JJ; Rabinowitz JD; Tejero H; Al-Shahrour F; Hidalgo M; Maitra A; Dang CV
Clin Cancer Res; 2017 Sep; 23(18):5639-5647. PubMed ID: 28611197
[No Abstract] [Full Text] [Related]
6. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
Park JH; Kim YH; Park EH; Lee SJ; Kim H; Kim A; Lee SB; Shim S; Jang H; Myung JK; Park S; Lee SJ; Kim MJ
Cancer Sci; 2019 Sep; 110(9):2834-2845. PubMed ID: 31278880
[TBL] [Abstract][Full Text] [Related]
8. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
9. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
[TBL] [Abstract][Full Text] [Related]
10. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
[TBL] [Abstract][Full Text] [Related]
11. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
Janzer A; German NJ; Gonzalez-Herrera KN; Asara JM; Haigis MC; Struhl K
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10574-9. PubMed ID: 25002509
[TBL] [Abstract][Full Text] [Related]
12. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.
Liu X; Gan B
Cell Cycle; 2016 Dec; 15(24):3471-3481. PubMed ID: 27792451
[TBL] [Abstract][Full Text] [Related]
13. Phenformin as prophylaxis and therapy in breast cancer xenografts.
Appleyard MV; Murray KE; Coates PJ; Wullschleger S; Bray SE; Kernohan NM; Fleming S; Alessi DR; Thompson AM
Br J Cancer; 2012 Mar; 106(6):1117-22. PubMed ID: 22361631
[TBL] [Abstract][Full Text] [Related]
14. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
Wang J; Xia S; Zhu Z
Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
[TBL] [Abstract][Full Text] [Related]
16. Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
Jung CL; Mun H; Jo SY; Oh JH; Lee C; Choi EK; Jang SJ; Suh YA
Oncotarget; 2016 Nov; 7(47):77664-77682. PubMed ID: 27765910
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Repurposing of Biguanides in Cancer.
Zhao H; Swanson KD; Zheng B
Trends Cancer; 2021 Aug; 7(8):714-730. PubMed ID: 33865798
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF.
Shao W; Mishina YM; Feng Y; Caponigro G; Cooke VG; Rivera S; Wang Y; Shen F; Korn JM; Mathews Griner LA; Nishiguchi G; Rico A; Tellew J; Haling JR; Aversa R; Polyakov V; Zang R; Hekmat-Nejad M; Amiri P; Singh M; Keen N; Dillon MP; Lees E; Ramurthy S; Sellers WR; Stuart DD
Cancer Res; 2018 Mar; 78(6):1537-1548. PubMed ID: 29343524
[TBL] [Abstract][Full Text] [Related]
19. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
Hung LVM; Moon JY; Ryu JY; Cho SK
Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
[TBL] [Abstract][Full Text] [Related]
20. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
